603233.SH
DaShenLin Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 18.29
−1.03%Forward multiples
Based on analyst estimates
- P/E forward
- 14.37x
- P/E 2026E
- 14.11x
- P/E 2027E
- 12.22x
- P/E 2028E
- 10.82x
- P/S forward
- 0.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.48x
- PEG TTM
- 1.21x
- Price / book
- 3.05x
- Price / sales
- 0.79x
- Price / cash flow
- 4.78x
Enterprise value
- Enterprise value
- CNY 18.8B
- EV / sales
- 0.68x
- EV / EBITDA
- 7.84x
- EV / EBIT
- 9.79x
- Market cap
- CNY 21.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026